$20.50
Today
as of Jul 22, 16:56 ET
Last 30 days
Recent Press Releases & News
Zai Lab to Announce Second Quarter 2026 Financial Results and Recent Corporate Updates on August 6, 2026
Zai Lab Limited (ZLAB) Gains EMA Orphan Drug Designation for DLL3-Targeting Cancer Therapy
Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing
Overview
52-week range
$16
$44
16% of range
Avg surprise (last 3)
+10.2%
Avg reaction (last 2)
-1.6%
50% positive
Latest IV / EM
90%
EM ±20.9% · $20 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.46 | $-0.58 | +20.7% | -2.2% | -5.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.03 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.37 | $-0.37 | 0.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.45 | $-0.50 | +10.0% | — | +2.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.04 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.08 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.05 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.13 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | — | -$0.37 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $100M | — | $116M | $110M | $106M | — | $102M | $101M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-69M | — | $-49M | $-55M | $-56M | — | $-68M | $-76M |
| Net income | $-51M | — | $-36M | $-41M | $-48M | — | $-42M | $-80M |
| EPS (diluted) | $-0.05 | — | $-0.03 | $-0.04 | $-0.04 | — | $-0.04 | $-0.08 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $651M | $680M | $717M | $732M | $757M | $450M | $616M | $630M |
| Inventory | $86M | $75M | $67M | $62M | $53M | $40M | $40M | $42M |
| Total current assets | $945M | $1.02B | $1.03B | $1.03B | $1.04B | $1.05B | $861M | $870M |
| Total assets | $1.10B | $1.17B | $1.16B | $1.16B | $1.17B | $1.19B | $985M | $987M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $434M | $457M | $399M | $372M | $363M | $345M | $318M | $283M |
| Total equity | $662M | $716M | $760M | $792M | $811M | $841M | $668M | $704M |